Africa Liver Cancer Guidelines

Pour le français, veuillez cliquer ici >>

| Inscription gratuite |

--

Liver cancer is the fourth most common cancer for both genders in Africa. Viewed as a whole, the risk factors in Africa are similar to those encountered in other parts of the world. However, these risk factors appear to differ by region. Many of the risk factors could be avoided with comprehensive national strategies, medical advice, and personal decisions that are guided by appropriate education. Prevention strategies include vaccination against hepatitis B and the fight against aflatoxin. In Africa, where majority of the countries are low-middle income the costly nature of theses measures remain an impediment.

The overall survival of liver cancer stands out at only 3 months in Africa compared to other regions in the world. This is mainly driven by late-stage presentation and limited access to the most novel therapeutic approaches. The hands-on experience of several members of the steering committee about the limited available options or the applicability of alternative approaches for surveillance and therapy would help validate the appropriate and accessible management. The combination of local risk factors, economics, culture, and potentially biology create a unique environment for each region. Therefore, the guidelines designed for one environment may not translate well to another. This justifies the critical need for prevention, early detection and treatment guidelines that reflect the available and alternative options across the continent.

A key element of the proposed initiative is to join the entire African continent under the same guidelines with added distribution, based on geo-economic GDP per capita regions. An example is the NCCN Harmonized Guidelines for Sub-Saharan Africa, which is based on the NCCN North America guidelines, but highlight solely the available treatment options in Sub-Saharan Africa. The Middle East North Africa (MENA) region NCCN initiatives aim to cover Northern Africa.

Live Virtual Format

This live conference will take place virtually over two half-days and will be delivered using Zoom. The program will consist of introductory lectures from experts in Africa and the United States as well as interactive sessions where all attendees are encouraged to provide input in helping to build liver cancer guidelines for Africa. We are excited to bring together colleagues in Africa and from around the world to help with this initiative. After this program, we aim to publish the guidelines, distribute them throughout Africa, and present them at major medical meetings. We anticipate the need to host this program annual to continue analyzing the effectiveness of the guidelines.

DAY 1: October 19th
7:00-11:05 am (New York)
11:00 am-3:05 pm (GMT)

DAY 2: October 20th
7:00 am-12:00 pm (New York)
11:00 am-4:00 pm (GMT)

We do recommend you use The Time Zone Converter to ensure you have the accurate date and time for this program based on your location. Additionally, We encourage all attendees to download the Zoom app prior to the start of the course (zoom.us/download).

Who Should Attend

1. Affirm current correct prevention and therapeutic practices
2. Rectify and update current prevention and therapeutic practices
3. Develop joint African continent HCC guidelines for surveillance, prevention, and treatment
4. Evaluate guidelines based on geo-economic GDP per capita regions

Registration is closed for this program. Please email [email protected]. if you have any questions

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 8.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.00 Medical Knowledge MOC points and patient safety MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Course Directors 

Ghassan K. Abou-Alfa, MD, MBA
Professor 
Memorial Sloan Kettering Cancer Center
New York, NY, USA

Ashraf Omar, MD
Professor 
University of Cairo 
Cairo, Egypt

Course Faculty

Mary Afihene, MD
Faculty, Professor
Signetcare Medical Services
Kumasi, Ghana

Adwoa Afrakoma Agyei-Nkansah, MD
Faculty, Professor
University of Ghana 
School of Medicine and Dentistry
Accra Ghana

Olusegun Isaac Alatise, MD
Faculty, Professor
Obafemi Awolowo University Teaching 
Hospital Complex
Ile-Ife, Nigeria

Akwi Asombang, MD
Faculty, Professor
Massachusetts General Hospital
Harvard Medical School
Boston, MA, USA

Fiyinfolu (Folu) Balogun, MD
Faculty, Professor
Memorial Sloan Kettering Cancer Center
New York, NY, USA

Alain Bougouma, MD
Faculty, Professor
Centre Hospitalier Universitaire Yalgado 
Burkina Faso

Adda Bounedjar, MD
Chairman of Medical Oncology
Anti Cancer Center 
Blida, Algeria

Lina Cunha, MD
Faculty, Professor
Hospital Privado De Maputo
Maputo, Mozambique 

Lisa M. DeAngelis, MD
Physician-in-Chief and Chief Medical Officer
Memorial Sloan Kettering Cancer Center 
New York, NY, USA

Papa Saloum Diop, MD
Faculty, Professor
Université Cheikh Anta DIOP
Dakkar, Senegal

Reda Elwakil, MD 
Emeritus Professor of Tropical Medicine
Faculty, Professor
Ain Shams University 
Cairo, Egypt

Eloumou Bagnaka Servais Albert Fiacre, MD
Head of Internal Medicine Unit
Douala University 
Douala, Cameroon

Eduard Jonas, MD
Faculty, Professor
UCT Private Academic Hospital 
Cape Town, South Africa 

Stephen Kimani, MD
Faculty, Professor
University of North Carolina at Chapel Hill
Chapel Hill, NC, USA

Peter Kingham, MD
Faculty, Professor
Memorial Sloan Kettering Cancer Center 
New York, NY, USA

Reshad Kurrimbukus, MD
Faculty, Professor
Jeetoo Hospital and Bruno Cheong Hospital
Port Louis, Mauritius

Hailemichael Desalegn Mekonnen, MD
Faculty, Professor
St. Paul’s Hospital Millennium Medical College
Addis Ababa, Ethiopia

Ali Mahamat Moussa Ali, MD
Faculty, Professor
University of N’Djamena 
Chad

Ntokozo Ndlovu, MD
Faculty, Professor
University of Zimbabwe College of Health Sciences 
Harare, Zimbabwe

Jerry Ndumbalo, MD
Faculty, Professor
Ocean Road Cancer Institute 
Dar es Salaam, Tanzania 

Lewis Roberts, MD
Advisor, Faculty, Professor
Mayo Clinic
Rochester, MN, USA

Vikash Sewram, PhD (Public Health & Fam. Med.), MPH (Epidemiol.)
Faculty, Professor, Director
African Cancer Institute, Stellenbosch University
Cape Town, South Africa 

Wendy Spearman, MBChB, FCP, FRCP, MMed, PhD
Faculty, Professor
University of Cape Town
Cape Town, South Africa

Precious Takondwa Makondi, MBBS, PhD
Faculty, Professor
Kamuzu Central Hospital - National Cancer Center
Lilongwe, Malawi

Christian Tzeuton, MD
Faculty, Professor
Yaounde University and Douala University
Cameroon

Ju Dong Yang, MD
Advisor, Faculty, Professor
Cedars-Sinai Medical Center 
Los Angeles, CA, USA

Faculty Disclosures (All Faculty and Planners)

Memorial Sloan Kettering gratefully acknowledges the following organizations for providing educational grants for this live activity:

AstraZeneca
Autem Medical
BeiGene
Berry Oncology Co., LTD
Yiviva, Inc.